Jadenu Interactions
There are 599 drugs known to interact with Jadenu (deferasirox), along with 6 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 206 are major, 380 are moderate, and 13 are minor.
- View all 599 medications that may interact with Jadenu
- View Jadenu alcohol/food interactions (2)
- View Jadenu disease interactions (6)
Most frequently checked interactions
View interaction reports for Jadenu (deferasirox) and the medicines listed below.
- Actemra (tocilizumab)
- Adempas (riociguat)
- Afinitor (everolimus)
- Ambien (zolpidem)
- amitriptyline
- Aralast NP (alpha 1-proteinase inhibitor)
- Aranesp (darbepoetin alfa)
- baclofen
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- biotin
- Bosulif (bosutinib)
- Eliquis (apixaban)
- folic acid
- furosemide
- gabapentin
- Gleevec (imatinib)
- hydroxyurea
- Jakafi (ruxolitinib)
- metformin
- Neupogen (filgrastim)
- pantoprazole
- Promacta (eltrombopag)
- Seroquel (quetiapine)
- trazodone
- Vidaza (azacitidine)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
Jadenu alcohol/food interactions
There are 2 alcohol/food interactions with Jadenu (deferasirox).
Jadenu disease interactions
There are 6 disease interactions with Jadenu (deferasirox) which include:
- bone marrow suppression
- dermatologic toxicities
- hepatic impairment
- renal dysfunction
- auditory and ocular abnormalities
- GI complication
Report options
More about Jadenu (deferasirox)
- Jadenu consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: chelating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Ferriprox
Ferriprox (deferiprone) is used to treat patients with iron overload caused by blood transfusions ...
Exjade
Exjade is used to treat iron overload caused by blood transfusions. Learn about side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Reblozyl
Reblozyl is used to treat anemia in adults with beta-thalassemia or myelodysplastic syndromes ...
Zynteglo
Zynteglo (betibeglogene autotemcel) is a gene therapy indicated for the treatment of patients with ...
Casgevy
Casgevy (exagamglogene autotemcel) is a gene therapy that is given as a one-time intravenous ...
Luspatercept
Luspatercept (brand name Reblozyl) is used to treat anemia (low red blood cells) in certain ...
Deferiprone
Deferiprone systemic is used for hemosiderosis, iron overload, superficial siderosis, thalassemia
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
